Archives
How Mc-VC-PAB-SN38 Links Design to DNA Damage
2026-11-20
Mc-VC-PAB-SN38 is best interpreted as a cleavable linker–SN38 construct whose intended value lies in connecting antibody-drug-conjugate delivery with a topoisomerase I inhibitor. Its molecular design supports a testable mechanistic hypothesis, but product documentation alone does not establish selective uptake, release kinetics, cytotoxic potency, or therapeutic performance.
Why the CSN2 Locus Matters in Rabbit Pharming
2026-11-20
A 2025 study links targeted insertion at the rabbit CSN2 milk-protein locus with markedly higher tdTomato levels in milk. The findings support a locus-and-promoter mechanism, but they do not yet establish equivalent performance for therapeutic proteins, product quality, animal health, or manufacturing-scale reproducibility.
HNRNPU Lactylation and Cervical Cancer Metabolism
2026-11-19
A literature-focused analysis of how HNRNPU K181 lactylation links lactate signaling to PHGDH expression, serine metabolism, and cervical cancer growth, while distinguishing genetic evidence from the more confounded pharmacological results and the separate control role of (R)-MG132.
Phosphorylated H1 at Stressed Replication Forks
2026-11-19
A mechanistic study links S-phase phosphorylation of linker histone H1 to stronger association with fork-associated single-stranded DNA, recruitment of HPF1 and other DNA-damage-response factors, and maintenance of genome integrity. The evidence is convergent across biochemical, imaging, cellular rescue, proteomic, and lymphoma-dataset analyses, while several conclusions remain dependent on phosphomimic substitutions and qualitative assembly measurements.
(S)-(+)-Methoprene and Locust JH Control
2026-11-18
Li and colleagues connect stage-dependent microRNA repression with juvenile hormone biosynthesis, vitellogenin production, and ovarian development in migratory locusts. The study’s methoprene perturbation supports a pathway-level role for juvenile hormone in reproduction, while the molecular data provide the stronger evidence for coordinated miRNA–mRNA regulation.
A Milk-Protein Locus for Rabbit Pharming
2026-11-18
A 2025 study tested whether placing a recombinant reporter gene at the rabbit CSN2 milk-protein locus could overcome the variable expression associated with conventional transgenic animal production. The reported milk concentrations were substantially higher than historical rabbit pharming yields, but the evidence remains a proof of concept because it is based on a reporter protein and a small number of homozygous animals.
How CSN2 Targeting Raised Rabbit Milk Yields
2026-11-17
A 2025 study used targeted insertion at the rabbit CSN2 locus to place a reporter gene under the control of an endogenous milk-protein promoter. The resulting line produced 15–20 g/L of tdTomato in milk, but the evidence remains a proof of concept rather than a validation of therapeutic-protein manufacturing.
What High-Yield Rabbit Pharming Evidence Shows
2026-11-17
A recent rabbit study reports markedly higher milk concentrations of a fluorescent recombinant protein after targeted insertion at the endogenous CSN2 locus. The result supports a strong locus-and-promoter hypothesis, but its generalizability to therapeutic proteins, animal-wide productivity, and manufacturing performance remains unresolved.
Why the CSN2 Locus Raises Rabbit Milk Protein Yield
2026-11-16
A mechanistic analysis of targeted expression at the rabbit CSN2 locus, the evidence behind reported tdTomato yields of 15–20 g/L, and the limits of comparison with conventional pharming lines.
Why CSN2 Targeting Raised Rabbit Pharming Yield
2026-11-16
A 2025 study tested whether placing a reporter transgene at the endogenous rabbit CSN2 milk-protein locus could improve expression in milk. Its reported 15–20 g/L output in two homozygous females is notable, but the result remains a proof of concept because the protein was tdTomato, the high-yield cohort was small, and historical comparisons were not matched head-to-head.
Dual-Target CAR-T: Mechanism and Measurement
2026-11-15
A source-grounded interpretation of how simultaneous CD276 and NKG2D-ligand recognition may reduce antigen-escape failure in non-small cell lung cancer, and how chemiluminescent protein detection supports—but does not establish—the mechanistic conclusions.
H-89 in Wnt–O-GlcNAc Bone Signaling
2026-11-14
A mechanistic interpretation of how H-89 can interrogate the PKA-linked branch of Wnt-driven O-GlcNAcylation, glycolysis, and osteogenesis, while distinguishing pharmacological evidence from stronger genetic and metabolic findings.
What High-Yield Rabbit Pharming Evidence Shows
2026-11-13
A primary rabbit study reports 15–20 g/L tdTomato in milk from two homozygous females after targeted insertion at the endogenous CSN2 locus. The finding supports a locus- and promoter-based explanation for higher expression, but historical controls, the small biological sample, reporter choice, and unmeasured product-quality endpoints limit claims about general pharming performance.
What High-Yield Rabbit Pharming Evidence Shows
2026-11-13
A published rabbit study links targeted expression at the endogenous CSN2 locus with markedly higher reporter-protein concentrations in milk. The result is promising, but cross-study comparisons, a small directly observed animal set, and the use of tdTomato leave important questions about reproducibility, protein-specific performance, and translational relevance.
Why CSN2 Targeting Raises Rabbit Milk Yield
2026-11-12
A 2025 study links targeted expression at the endogenous CSN2 milk-protein locus with markedly higher reporter-protein concentrations in rabbit milk. The evidence supports a promoter-and-locus mechanism, but its generality is limited by the reporter model, small number of high-yield animals, and lack of a matched head-to-head comparison.